skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sequential hemi-body irradiation (HBI) in treatment of advanced neuroblastoma: a pilot study

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

Eight patients between 13 months and 15 years old with Stage IV neuroblastoma were treated between December, 1978 and March, 1980 with half body irradiation in addition to multidrug chemotherapy. Three patients had HBI after completion of treatment. Five patients had HBI concomitantly with chemotherapy, of these 4 are alive. The mean survival time of the patients who died is 15 months, 2 patients are alive with disease at 18 and 25 months and 2 are disease free at 16 and 19 months from diagnosis. The main side effect of treatment was bone marrow depression. HBI did not significantly increase the toxicity produced by chemotherapy.

Research Organization:
Memorial Sloan-Kettering Cancer Center, New York, NY
OSTI ID:
6231983
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 7:4
Country of Publication:
United States
Language:
English